Recent Company News

• 10:43 PM ET Aug 12, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (65 total)

• 11:17 PM ET Aug 11, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (78 total)

• 10:36 PM ET Aug 03, 2026
  

  Teijin reports Q1 net income attributable ¥59.83B vs FactSet ¥33B [2 est, ¥31.40-34.60B] (¥1630.5000, +12.5)

• 09:01 PM ET Jul 21, 2026
  

  StreetAccount Sector Preview - Japan Chemicals Apr-Jun Earnings

• 11:04 PM ET Jul 02, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 03:04 AM ET Jun 19, 2026
  

  Teijin pharma receives Japan MHLW approval for additional indication of Xeomin (¥1594.5000, 0)

• 09:32 PM ET Jun 16, 2026
  

  Teijin to transfer manufacturing and marketing approvals for certain drugs to LTL Pharma

• 11:40 PM ET Jun 13, 2026
  

  Ascendis Pharma announces Week 182 data from PaTHway Trial ($218.06, 0.00)

• 04:05 PM ET Jun 11, 2026
  

  5-Year Phase 2 data show TransCon PTH replicated systemic actions of endogenous PTH in adults with hypoparathyroidism ($215.60, 0.00)

• 10:57 PM ET May 13, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (225 total)